{"id":181086,"date":"2025-09-25T15:45:09","date_gmt":"2025-09-25T15:45:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/181086\/"},"modified":"2025-09-25T15:45:09","modified_gmt":"2025-09-25T15:45:09","slug":"is-hsic-underperforming-the-health-care-sector","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/181086\/","title":{"rendered":"Is HSIC Underperforming the Health Care Sector?"},"content":{"rendered":"\n<p class=\"yf-1090901\">Valued at a market cap of\u00a0$8.2 billion, Henry Schein, Inc. (HSIC) is a leading global provider of healthcare products and services, specializing in serving office-based dental and medical practitioners. Headquartered in Melville, New York, the company operates in 33 countries and territories, employing over 25,000 Team Schein members worldwide.<\/p>\n<p class=\"yf-1090901\">Companies valued between $2 billion and $10 billion are generally classified as \u201cmid-cap stocks,&#8221; and\u00a0Henry Schein fits this criterion perfectly. With a selection of more than 120,000 branded products and Henry Schein private-label offerings, the company supports more than 1 million customers globally. Additionally, its integrated approach, extensive product offerings, and commitment to ethical business practices position it as a prominent player in the healthcare industry.<\/p>\n<p class=\"yf-1090901\">However, Henry Schein currently trades 17.9% below its\u00a052-week high of $82.49\u00a0recorded on Feb. 5.\u00a0HSIC&#8217;s stock\u00a0has dropped 6.8%\u00a0over the past three months, lagging behind the Health Care Select Sector SPDR Fund&#8217;s (XLV)\u00a02% rise\u00a0over the same time frame.<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"eager\" height=\"521\" width=\"780\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">Longer term, Henry Schein\u2019s stock has plunged 2.1% on a YTD basis, whereas XLV has decreased marginally. Moreover, shares of\u00a0HSIC have slumped 4.2% over the past 52 weeks, underperforming the\u00a0ETF\u2019s 11.5% returns\u00a0over the same time frame.<\/p>\n<p class=\"yf-1090901\">The stock has slipped below its 50-day and 200-day moving averages since the end of July, indicating a downtrend.<\/p>\n<p>    <img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"lazy\" height=\"526\" width=\"782\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">Shares of HSIC fell 7.4% on Aug. 5 after the company reported Q2 2025 earnings. While its adjusted EPS of $1.10 fell short of Wall Street forecasts, revenue of $3.2 billion beat expectations. The earnings miss was driven by sluggish demand for U.S. dental products, as high interest rates, inflation, and lower spending on non-urgent procedures like orthodontics and high-end restoratives weighed on performance.<\/p>\n<p class=\"yf-1090901\">In the healthcare sector, top rival Cardinal Health, Inc. (CAH), has notably outperformed HSIC stock. Shares of CAH have\u00a0gained 30.7%\u00a0on a YTD basis and climbed 40.3% over the past 52 weeks.<\/p>\n<p class=\"yf-1090901\">Nevertheless, among the 15 analysts covering the HSIC stock, the consensus rating is a \u201cModerate Buy.\u201d Its mean price target of $73.23 suggests an 8.1% upside potential from current price levels.<\/p>\n<p class=\"yf-1090901\"> On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally\u00a0published on <a href=\"https:\/\/www.barchart.com\/story\/news\/35029456\/henry-schein-stock-is-hsic-underperforming-the-health-care-sector?utm_source=yahoo&amp;utm_medium=syndication&amp;utm_content=footer_link\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Barchart.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Barchart.com<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"Valued at a market cap of\u00a0$8.2 billion, Henry Schein, Inc. (HSIC) is a leading global provider of healthcare&hellip;\n","protected":false},"author":2,"featured_media":181087,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[97,252,253,66661,107175,107174,107178,107177,107176],"class_list":["post-181086","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-health","tag-health-care","tag-healthcare","tag-healthcare-industry","tag-healthcare-products","tag-henry-schein-inc","tag-hsic-stock","tag-medical-practitioners","tag-team-schein"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/181086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=181086"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/181086\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/181087"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=181086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=181086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=181086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}